← Open Payments lookup

SUSIE LEE: Open Payments

NPI 1194141523 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,717 in 120 payments from 21 companies in 2025. Trend: 2023 $1,452 · 2024 $2,173 · 2025 $4,717

Food & beverage: $2,829Travel & lodging: $1,357Education: $357Consulting: $175
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.15$1,813
Novartis Pharmaceuticals Corporation30$638
Astellas Pharma US Inc6$365
Janssen Biotech, Inc.10$264
Alexion Pharmaceuticals, Inc.5$257
AstraZeneca Pharmaceuticals LP11$236
SOBI, INC5$226
GENZYME CORPORATION7$203
BeOne Medicines USA, Inc.9$196
Incyte Corporation4$99

Products named: Fabhalta, CALQUENCE, ULTOMIRIS, BRUKINSA, TECVAYLI, Doptelet, AYVAKIT, SCEMBLIX.

Industry payments across CA — which companies pay providers there.